J. Knight

发表

Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure.

M. Higginbotham, F. Cobb, M. J. Sullivan, 1989, Circulation.

Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry.

D. Mark, J. O’Keefe, W. O’Neill, 1995, Journal of the American College of Cardiology.

Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.

K. Anstrom, D. Mark, P. Cowper, 2008, American heart journal.

An introduction to the Kidney Check Australia Taskforce

J. Knight, 2002 .

An introduction to the KidneyCheck Australia Taskforce

J. Knight, 2002 .

Cost avoidance through early discharge of the uncomplicated acute myocardial infarction patient

R. Califf, L. Shaw, D. Mark, 1996 .

K. Anstrom, D. Mark, D. Prabhakaran, 2016, American heart journal.

D. Prabhakaran, P. Armstrong, E. Ohman, 2016 .

Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.

Manesh R. Patel, K. Anstrom, D. Mark, 2016, Annals of internal medicine.

Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.

K. Lee, R. Califf, D. Mark, 1994, The New England journal of medicine.

Regional variations in treatment costs and resource utilization for uncomplicated acute myocardial infarction (UMI)

R. Califf, L. Shaw, D. Mark, 1996 .

Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.

K. Anstrom, D. Mark, R. Lopes, 2020, The Journal of thoracic and cardiovascular surgery.

Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.

R. Califf, D. Mark, E. Topol, 1999, Circulation.

Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.

R. Califf, D. Mark, P. Armstrong, 2003, American heart journal.

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.

R. Califf, D. Mark, P. Armstrong, 1999, Journal of the American College of Cardiology.

Evaluating the Potential ‘Economic Attractiveness’ of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome

R. Califf, D. Mark, J. Jollis, 2000, PharmacoEconomics (Auckland).

Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application

Jeffrey G. Gray, Eric L. Eisenstein, Eric D. Peterson, 1997, AMIA.

Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.

K. Anstrom, I. Piña, C. O'connor, 2018, Journal of the American College of Cardiology.

Quality-of-Life Outcomes With Coronary Artery Bypass Graft Surgery in Ischemic Left Ventricular Dysfunction

K. Anstrom, D. Mark, J. Spertus, 2014, Annals of Internal Medicine.

Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.

K. Anstrom, D. Mark, J. Spertus, 2009, American heart journal.

Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT).

G. Lamas, D. Mark, M. Sweeney, 2007, Heart rhythm.

How Reliable are Patient‐Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies

K. Anstrom, D. Mark, E. Peterson, 2016, Journal of the American Heart Association.

Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.

D. Mark, P. Armstrong, C. Granger, 2004, Canadian Journal of Cardiology.

Acute and 1‐Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE‐ACS Registry

D. Mark, E. Peterson, Tracy Y. Wang, 2019, Journal of the American Heart Association.

Economic Outcomes with Anatomic versus Functional Diagnostic Testing for Coronary Artery Disease

D. Mark, L. Cooper, P. Cowper, 2022 .

Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization: Results From the EPILOG Randomized Trial

R. Califf, D. Mark, E. Topol, 2000, Circulation.

Impact of Complete Revascularization in the ISCHEMIA Trial.

Kevin S. Chan, Sean M. O'Brien, G. Lamas, 2023, Journal of the American College of Cardiology.